Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,878.00p
   
  • Change Today:
    -13.00p
  • 52 Week High: 2,205.00
  • 52 Week Low: 1,722.00
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 7,336
  • Market Cap: £4,167.01m
  • RiskGrade: 125

Tuesday broker round-up

By Conor Coyle

Date: Tuesday 27 Jun 2017

LONDON (ShareCast) - (ShareCast News) - Abcam: Berenberg initiates at Buy with a target price of 1100p.
Mediclinic: Citi reiterates Neutral with a target price of 790p.

Standard Life: Deutsche Bank reiterates Hold with a target price of 420p.

BAE Systems: JPMorgan reiterates Neutral with a target price of 660p.

Experian: Macquarie reiterates Outperform with a target price of 1870p.

Hikma Pharmaceuticals: HSBC maintains Reduce with a target price of 1410p.

Rhythm One: Numis upgrades to Buy with a target price of 61p.

Shire Pharmaceuticals: Credit Suisse reiterates Outperform with a target price of 5350p.

WPP: Shore Capital downgrades to Hold.

Ascential: Berenberg reiterates Buy with a target price of 400p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,878.00p
Change Today -13.00p
% Change -0.69 %
52 Week High 2,205.00
52 Week Low 1,722.00
Volume 7,336
Shares Issued 221.89m
Market Cap £4,167.01m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average48.07% below the market average
1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average1.96% above the sector average
Price Trend
44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average44.88% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average11.05% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average31.5% below the market average
39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average39.39% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 01-Jul-2024

Time Volume / Share Price
09:17 1 @ 1,877.00p
09:16 100 @ 1,878.00p
09:16 62 @ 1,878.00p
09:15 1 @ 1,878.00p
09:14 9 @ 1,880.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page